Lina is living with CDD.
A DIFFERENT KIND OF
ANTISEIZURE MEDICATION
FOR PATIENTS WITH CDKL5
DEFICIENCY DISORDER (CDD)
ZTALMY is the first neuroactive steroid anticonvulsant
ZTALMY acts as a positive allosteric modulator of synaptic and extrasynaptic GABAA receptors.1,2 It is the first treatment indicated specifically for seizures associated with CDD in patients 2 years and older.3




